21. Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study. Issue 3 (14th June 2012) Authors: Misra, Vijay P; Ehler, Edvard; Zakine, Benjamin; Maisonobe, Pascal; Simonetta-Moreau, Marion Journal: BMJ open Issue: Volume 2:Issue 3(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Factors predicting long-term patient satisfaction with botulinum toxin treatment in cervical dystonia. (December 2018) Authors: Misra, Vijay P.; Colosimo, Carlo; Chung, Tae Mo; Charles, David; Om, Savary; Maisonobe, Pascal Journal: Toxicon Issue: Volume 156(2018)Supplement 1 Page Start: S81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis. Issue 3 (July 2021) Authors: Gracies, Jean-Michel; Francisco, Gerard E.; Jech, Robert; Khatkova, Svetlana; Rios, Carl D.; Maisonobe, Pascal Journal: Journal of neurologic physical therapy Issue: Volume 45:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. How satisfied are cervical dystonia patients after 3 years of botulinum toxin treatment?. (December 2018) Authors: Colosimo, Carlo; Misra, Vijay P.; Charles, David; Chung, Tae Mo; Maisonobe, Pascal; Om, Savary Journal: Toxicon Issue: Volume 156(2018)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice. (2020) Authors: Trosch, Richard M.; Misra, Vijay P.; Maisonobe, Pascal; Om, Savary Journal: Clinical parkinsonism & related disorders Issue: Volume 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III). Issue 6 (17th June 2016) Authors: Turner-Stokes, Lynne; Ashford, Stephen; Jacinto, Jorge; Maisonobe, Pascal; Balcaitiene, Jovita; Fheodoroff, Klemens Journal: BMJ open Issue: Volume 6:Issue 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Impact of patient input on the study execution of an observational study assessing the effectiveness of abobotulinumtoxinA treatment in leg spasticity management in adults. (January 2021) Authors: Esquenazi, Alberto; Maisonobe, Pascal; Sánchez, Carlos Durán; Lysandropoulos, Andreas; Ashford, Stephen Journal: Toxicon Issue: Volume 190(2021)supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Improvement in poststroke upper limb spasticity patterns after treatment with botulinum toxin A: A prospective observational study. (25th December 2016) Authors: Valls-Solé, Josep; Caballero, Fernanda Maria; Durà, Maria José; Guirao, Lluis; Bernabeu, Montserrat; Bascuñana, Helena; Garcia, Irene; Maisonobe, Pascal Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Integrated upper limb spasticity management including botulinum toxin A (BoNT-A) on patient-centred goal attainment: Methodology for ULIS-III and initial goal-setting data. (25th December 2016) Authors: Turner-Stokes, Lynne; Balcaitiene, Jovita; Ashford, Stephen; Jacinto, Jorge; Maisonobe, Pascal; Fheodoroff, Klemens Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Longitudinal goal attainment with integrated upper limb spasticity management including botulinum toxin A: Primary results from the ULIS-III study. (January 2021) Authors: Turner-Stokes, Lynne; Fheodoroff, Klemens; Jacinto, Jorge; Brashear, Allison; Maisonobe, Pascal; Lysandropoulos, Andreas; Ashford, Stephen Journal: Toxicon Issue: Volume 190(2021)supplement 1 Page Start: S74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗